Biocatalytic synthesis of some chiral drug intermediates by oxidoreductases

JAOCS, Journal of the American Oil Chemists' Society

Volumn 74, Issue 11, 1997, Pages 1345-1360

  Patel, Ramesh N ^a   Hanson, Ronald L ^a   Banerjee, Amit ^a   Szarka, Laszlo J ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Antihypertensive drug (ceronapril); Antipsychotic agent R (+) BMY 14802 ; Biocatalysis; Chiral drug intermediates; Monobactam (tigemonam); Oxidoreductases; blocker with class III antiarrhythmic properties (D sotalol)

Indexed keywords

OXY;

AMINO ACIDS; BIOTECHNOLOGY; CATALYSIS; ENZYME INHIBITION; SYNTHESIS (CHEMICAL);

ANTIHYPERSENSITIVE DRUG; BIOCATALYSIS; OXIDOREDUCTASES;

DRUG PRODUCTS;

EID: 0031277090     PISSN: 0003021X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11746-997-0237-3     Document Type: Article

References (58)

1. Sih, C.J., and C.S. Chen, Microbial Asymmetric Catalysis: Enantioselective Reduction of Ketones. Angew: Chem. Int. Engl. 23:570-578(1984).
2. Jones, J.B., Enzymes in Organic Synthesis. Tetrahedron 42:3351-3403(1986).
3. Csuz, R., and B.I. Glanzer. Baker's Yeast Mediated Transformations in Organic Chemistry. Chem. Rev. 91:49-97 (1991).
4. Crosby. J., Synthesis of Optically Active Compounds: A Large Scale Perspective, Tetrahedron 47:4789-4846 (1991).
5. Simon, H., J. Bader. H. Gunther. S. Neumann, and J. Thanos. Chiral Compounds Synthesized by Biocatalytic Reductions, Angew. Chem. Int. Engl. 24:539-553 (1985).
6. Stinson. S.C., Chiral Drugs, Chem. Eng. News, Sept. 28. 46-79 (1992).
7. Santaneillo, E., P. Ferraboschi, P. Grisenti. and A. Manzocchi. The Biocatalytic Approach to the Preparation of Enantiomerically Pure Chiral Building Blocks. Chem. Rev. 92:1071-1140 (1992).
8. Margolin, A.L., Enzymes in the Synthesis of Chiral Drugs, Enzyme Microb. Technol. 75:266-280 (1993).
9. Wong, C.-H., and G.M. Whitesides. Enzymes in Synthetic Organic Chemistry, Tetrahedron Organic Chemistry Series, 1994, Vol. 12, Pergamon, Elsevier Science Ltd., Oxford.
10. Patel R.N., A. Banerjee, M. Liu. R.L. Hanson. R.Y. Ko, J.M. Howell. and L.J. Szarka. Microbial Reduction of l-(4-Fluorophenyl)-4-[4-(5-fluoro-2-pyrimidinyI)-l-piperazinyl]butan-l-one. Biotechnol. Appl Biochem. 17:139-153 (1993).
11. Patel, R.N., A. Banerjee, C.J. McNamee, and L. Szarka, Stereo selective Microbial Reduction of N-(4-( l-Oxo-2-chloroacetyl Ethyl) Phenyl Methane Sulfonamide. J. Appl. Microbiol Biotechnol. 40: 241-245 (1993).
12. Hanson, R.L., J. Singh, T.P. Kissick, R.N. Patel, L.J. Szarka, and R.H. Mueller, Synthesis of L-β-Hydroxyvaline from α-Keto-βHydroxy-Isovalerate Using Leucine Dehydrogenase from Bacillus sp., Bioorg. Chem. 18:116-130 (1990).
13. Hanson, R.L., K.S. Bembenek, R.N. Patel, and L.J. Szarka. Transformation of N-ε-CBZ-L-Lysine to CBZ-L-Oxylysine Using L Amino Acid Dehydrogenase from Lcictobacillus confusus, Appl. Microbiol. Biotechnol. 37:599-603 (1992).
14. Ferris, C.D., D.J. Hirsch, B.P. Brooks, and S.H. Snyder, a Receptors: From Molecule to Man, J. Neurochem. 57:729-737 (1991).
15. Junien. J.L., and B.E. Leonard. Drugs Acting on σ and Phencyclidine Receptors: A Review of Their Nature, Function, and Possible Therapeutic Importance, Clin. Neuropharmacol. 12:353-374 (1989).
16. Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppter, and P.E. Gilbert, The Effect of Morphine-and Nalophrine-Like Drugs in the Nondependent and Morphine-Dependent Chronic Spinal Dog, J. Pharmacol. Exp. Ther. 797:517-530 (1976).
17. Walker, J.M., W.D. Bower. P.O. Walker, R.R. Matsumoto, B.D. Costa, and K.C. Rice, Sigma Receptors: Biology and Function, Pharmacol. Rev. 42:355-402 (1990).
18. Steinfels, G.F., S.W. Tam, and L. Cook, Electrophysiological Effects of Selective σ-Receptor Agonists. Antagonists, and the Selective Phencyclidine Receptor Agonist MK-801 on Midbrain Dopamine Neurons. Neuropsychopharmacology 2:201-207 (1989).
19. Massamiri, T., and S.P. Duckies. Multiple Vascular Effects of Sigma and PCP Ligands: Inhibition of Amine Uptake and Contractile Responses, J. Pharmacol. Exp. Ther. 253:124-129 (1990).
20. 1A Receptors, Eur. J. Pharm. 202:379-383 (1991).
21. Taylor. D.P., M.S. Eison, S.L. Moon, and F.D. Yocca. BMY14802: A Potential Antipsychotic with Selective Affinity fora-σ Binding Sites, Adv. Neuropsy. Psychopharm. 1:307-315 (1991).
22. Yevich, J.P., and W.G. Lobeck. Antipsychotic 1-Fluorophenylbutyl-4-(2-pyrimidinyl)piperazine Derivatives, U.S. Patent 4,605,655 (1986).
23. Yevich. J.P., J.S. New. and D.W. Smith, Synthesis and Biological Evaluation of l-(l,2-Benzisothiazol-3-yl)-and (1.2-Benzisoxazol-3-yl)piperazine Derivatives as Potential Antipsychotic Agents, J. Med. Chem. 29:359-369 (1986).
24. Bradford, M.M., A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Proteins Utilizing the Principle of Protein Dye Binding. Anal. Biochem. 72:248-254 (1976).
25. Larsen. A.A., and P.M. Lish, A New Bio-Isostere: Alkyl sulphonamido-Phenethanolamines, Nature 203:1283-1284 (1964).
26. Uloth, R.H., J.R. Kirk. W.A. Gould, and A.A. Larsen, Sulfonalidies. I. Monoalkyl-and Arylsulfonamidophenethanolamines. J. Med. Chem. 9:88-96 (1966)
27. Lish, P.A., J.H. Weikel. and K.W. Dungan. Pharmacological and Toxicological Properties of Two New β-Adrenergic Receptor Antagonists, J. Exp. Ther. 149:161-173 (1965).
28. Somani. P., and T. Bachand. Blockade of Cardiac Effect oflso proterenol by the Stereoisomers of Sotalol. Eur. J. Pharmacol. 7:239-247 (1969).
29. Karanewsky. D.S., M.C. Badia. D.W. Cushman. J.M. DeForrest. T. Dejneka. M.J. Loots. M.G. Perri. E.W. Petrillo. Jr., and J.R. Powell. (Phosphinyloxy)Acyl Amino Acid Inhibitors of Angiotensin Converting Enzyme (ACE). 1. Discovery of(S)-1[6-Amino-2-[[hydroxy(4-phenylbutyl) phosphmyl]oxy]l-oxo-hexyl]-L-proline, a Novel Orally Active Inhibitor of ACE. J. Med. Chem. 31:204-212 (1988).
30. Haskell. T.H., R. Rodebaugh. N. Plessas. D. Watson, and R.D. Westland. The Preparation and Biological Activity of Novel Amino Acid Analogs of Butirosin, Carbohydr. Res. 28:263-280 (1973).
31. Berezov, T.T., and E.V. Lukasheva, Effect of Substrate and Product Analogs on the Activity of L-Lysine α-Oxidase from Trichoderma sp., Biochem. Int. 77:529-534 (1988).
32. Jemal, M., and A.I. Cohen, Determination of Enantiomeric Purity of Z-Oxylysine by Capillary Gas Chromatography. J. Chromatogr. 394:388-394 (1987).
33. Szwajcer, E., P. Brodelius. and K. Mosbach. Production of αKeto Acids: 2. Immobilized Whole Cells of Providencia sp. PCM 1298 Containing L-Amino Acid Oxidase. Enzyme Microb. Technol 4: 409-413 (1982).
34. Meister, A., The α-Keto Analogues of Arginine, Ornithine and Lysine. J. Biol. Chem. 206:577-585 (1954).
35. Kusakabe, H., K. Kodama, A. Kuninaka, H. Yoshino, H. Misono, and K. Soda, A New Antitumor Enzyme. L-Lysine α-Oxidase from Trichoderma viride. Purification and Enzymological Properties, Ibid. 255:976-981 (1980).
36. Schütte, H., W. Hummel, and M.R. Kula. L-2-Hydroxyisocaproate Dehydrogenase: A New Enzyme from Laciibacillus confusus for the Stereospecific Reduction of 2-Ketocarboxylic Acids. Appl. Microbiol. Biotechnol. 19: 167-176 (1984).
37. Pelmont. J., G. Arlaud, and A.M. Rossat. L-Aminoacide oxydases des envelopes des Proteus mirabilis: Properties generales, Biochimie 54:1359-1374 (1972).
38. Duerre, J.A., and S. Chakrabarty, L-Amino Acid Oxidase of Proteus rettgeri, J. Bacteriol 121:656-663 (1975).
39. Williams. R.M., Asymmetric Synthesis of D-β-Hydroxyvaline. in Synthesis of Optically Active α-Amino Acids (edited by J.E. Baldwin and P.D. Magnus). Pergamon, Oxford/New York. 1989. Vol. 7. pp. 185-195.
40. Kamphuis. J., W.H. Boesten, Q.B. Broxterman, H.F.M. Hermes, J.A.M. van Balken. E.M. Meijer. and H.E. Shoemaker, New Developments in Chemo-Enzymatic Production of Amino Acids, Adv. Biochem. Eng. Biotechnol. 42:134-186 (1990).
41. 4L Sykes, R.B., C.M. Cimarusti. D.P. Bonner. K. Bush. D.M. Floyd, N.H. Georgopadakou. W.H. Koster, W.C. Liu. W.L. Parker, P.A. Principle, M.L. Rathnum. W.A. Slusarchyk. W.H. Trejo, and J.S. Wells, Monocyclic β-Lactam Antibiotics Produced by Bacteria, Nature (London) 297:489-191 (1981).
42. Parker, W.L., J. O'Sullivan, and R.B. Sykes, Naturally Occurring Monobactams, Adv. Appi Microbiol. 31:181-205 (1986).
43. Roemmele, R.C., and H. Rapoport. Chirospecific Synthesis of β-Hydroxy-α-Amino Acids, J. Org. Chem. 54:1866-1875 (1989).
44. Ito. Y., M. Sawamura. E. Shirakawa. K. Hayashizaki. and T. Hayashi. Asymmetric Synthesis of β-Hydroxy-α-alkylamino Acids by Asymmetric Aldol Reaction of α-Isocyanocarboxylates Catalyzed by Chiral Ferrocenylphosphine-Gold(I) Complexes. Tetrahedron 44:5253-5262 (1988).
45. Guanti. G., L. Banfi. and E. Narisano. Enantiospecific and Diastereoselective Synthesis of Anti α-Hydrazo-and α-Amino-αHydroxyacids Through "Electrophilic Amination" of β-Hydroxyesters. Ibid. 44:5553-5562 (1988).
46. Evans, D.A., E.B. Sjogren, A.E. Weber, and R.E. Conn, Asymmetric Synthesis of Anti-β-hydroxy-α-amino acids. Tetrahedron Lett. 23:39-42(1987).
47. Gordon. E.M., M.A. Ondetti. J. Pluscec, C.M. Cimarusti, D.P. Bonner, and R.B. Sykes. O-Sulfated β-Lactam Hydroxamic Acids (Monosulfactams). Novel Monocyclic β-Lactam Antiobiotics of Synthetic Origin. J. Amer. Chem. Soc. 704:6053-6060 (1982).
48. Parker. W.L., E.M. Cohen. and W.H. Koster, U.S. Patent 4,741,220 (1988).
49. Slusarchyk, W.A., T. Dejneka. J.Z. Gougoutas. W.H. Koster, D.R. Kronenthal. M.F. Malley, M.G. Perri. F.L. Routh, J.E. Sundeen. E.R. Weaver. R. Zahler. J.D. Godfrey. R.H. Mueller. and D.J. Langen. β-Lactam Synthesis: Chemospecific Sulfonation and Cyclization of the β-Hydroxyvaline Nucleus. Tetrahedron Lett. 27:2789-2792 (1986).
50. Godfrey, J.D., R.H. Mueller, and D.J. Van Langen, β-Lactam Synthesis: Cyclization vs. 1,2-AcyI Migration-Cyclization. The Mechanism of the 1,2-Acyl Migration-Cyclization, Ibid. 27:2793-2796 (1986).
51. Edwards, G.W., and M.L. Minthorn, Jr., Preparation and Properties of the Optical Antipodes of β-Methoxyvaline and β-Hydroxyvaline. Canad. J. Biochem. 46:1227-1230 (1968).
52. Berse, C., and P. Bessette, A Novel Synthesis of β-Hydroxyvaline, Canad. J. Chem. 49:2610-2611 (1971).
53. Beyerman, H.C., L. Maat, D. De Rijke, and J.P. Visser, Absolute Configuration of β-Hydroxyvaline, Recl. Trav. Chim. Pays-Bas 86:1057-1060 (1967).
54. Schollkopf, U., J. Nozulak, and U. Groth. Asymmetrie Syntheses via Heterocyclic Intermediates xv. Enantioselective Synthe-sis of (R)-(-)-β-Hydroxyvaline Using L-Valine or (S)-O-O-Dimethyl-α-methyldopa as Chiral Auxiliary Reagents, Synthesis:868-870 (1982).
55. Wiechmann. R.,C. Wandrey. A.F. Buckmann, and M.-R. Kula, Continuous Enzymatic Transformation in an Enzyme Membrane Reactor with Simultaneous NAD(H)-Regeneration, Biotechnol. Bioeng. 23:2789-2802 (1981).
56. Schütte. H., W. Hummel. H. Tsai. and M. Kula, L-Leucine Dehydrogenase from Bacillus cereus, Appl Microbiol. Bioiechnol, 22:306-317(1985).
57. Monot. F., Y. Benoit, J. Lemal, A. Honorat, and D. Ballerini, Leucine Dehydrogenase from Bacillus megaterium, in Proceedings of the European Congress on Biochemistry, edited by O.M. Neijssel, R.R. van der Meer, and K.C.A.M. Luyben, Elsevier, Amsterdam. 1987, Vol. 2, pp. 42-45.
58. Oshima. T., H. Misono, and K. Soda. Properties of Crystalline Leucine Dehydrogenase from Bacillus sphaericus, J. Biol Chem. 253:5719-5725 (1978).